×

Access all guidelines and regulatory updates on

QuriousRI
×

Access all guidelines and regulatory updates on

QuriousRI

Artixio

Mexico

COFEPRIS Regulatory Compliance Services in Mexico

Trusted regulatory consulting covering compliance support, COFEPRIS local authorized representative services, and licensing guidance for life sciences companies in Mexico.

Product Approval and COFEPRIS Liaison Services

Artixio is a preferred partner for the Lifesciences industry, including global brands, small-medium enterprises, and startups across pharmaceuticals, biotech, medical devices, diagnostics, cosmetics, nutraceuticals, animal feed, and veterinary. Our deep domain expertise, combined with our proven experience, is committed to providing you with seamless assistance throughout your regulatory journey. We provide regulatory intelligence-based based tailored solutions for COFEPRIS compliance and leverage your Life Sciences product and excel in its safety, quality, and marketing standards.

We at Artixio provide comprehensive services that include regulatory affairs, product registration, label, artwork, market access, post-market entry, and maintenance services, and many more in the life science sector in Mexico. Our customer-focused focused experienced regional team efficiently provides tailored solutions for your Life Sciences product compliance. Our tech-enabled team helps you expedite your product commercialization and help achieve sustained compliance in the Mexican market.

Regulatory Authorities for Product Registration in Mexico

COFEPRIS

SENASICA

Providing structured compliance support, COFEPRIS local authorized representative services, and license consulting for life sciences companies operating in Mexico.

COFEPRIS Compliance Support in Mexico

COFEPRIS Local Authorized Representative Services

We provide local authorized representative services in Mexico for companies that need a reliable point of contact for COFEPRIS. This includes managing official communications, responding to authority requests, and supporting regulatory obligations tied to local presence requirements.

COFEPRIS Licensing Support

Our role as a COFEPRIS license consultant is not limited to applications alone. We also assist with changes, renewals, and regulatory questions that arise during inspections or operational updates.

Why Partner Artixio for COFEPRIS Regulatory Support in Mexico?

Compliance consulting services company
Expertise in Biopharmaceuticals, Devices, Cosmetics, Nutraceuticals, and Animal Health industries
Compliance consulting services company
ISO 9001:2015 certified quality assured team.
Compliance consulting services company
Proven success with product registrations and renewals in Mexico
Compliance consulting services company
Successful Approvals and Ongoing Product Lifecycle Maintenance for 200+ products.
Compliance consulting services company
Spanish-speaking regulatory experts ensuring smooth communication and submission
Compliance consulting services company
End-to-end support from product concept/prototype development, approval, and post-approval.
Compliance consulting services company
Strong understanding of local timelines, formats, and authority expectations
Compliance consulting services company
Trusted by global brands for reliable entry into the Mexican market

FAQs

How to approach the regulatory bodies in Mexico, and what are the modes of communication?
The regulatory body in Mexico is COFEPRIS, and it can be approached by a legal representative or consultant. Primary communications can be done through emails, online portals, or in-person query requests.
COFEPRIS takes a period of 6-12 months for the approval of Life Sciences products. However, there are fast-track options for critical and pandemic novel drug approval.
The fees associated with the COFEPRIS in Mexico are approximately 450 to 3,000 USD for pharmaceuticals, 850 to 1,500 USD for medical devices, and 500 to $2,000 USD for veterinary products. The cosmetics products are generally exempt from the approval fees by COFEPRIS but may be subject to importation charges.
COFEPRIS has its adverse event reporting system known as the Pharmacovigilance Unit (UFV). The adverse event can be reported by the healthcare professionals or MAH through the UFV online portal or through their reporting forms.

Our Global Reach: Serving Life Sciences Clients Worldwide

India Artixio – Regulatory affairs consulting expert

India

Singapore Artixio – Regulatory affairs consulting expert

Singapore

Mexico Artixio – Regulatory affairs consulting expert

Mexico

Brazil Artixio – Regulatory affairs consulting expert

Brazil

Vietnam Artixio – Regulatory affairs consulting expert

Vietnam

Malaysia Artixio – Regulatory affairs consulting expert

Malaysia

Argentina Artixio – Regulatory affairs consulting expert

Argentina

Colombia Artixio – Regulatory affairs consulting expert

Colombia

Taiwan Artixio – Regulatory affairs consulting expert

Taiwan

China Artixio – Regulatory affairs consulting expert

China

Europe Artixio – Regulatory affairs consulting expert

European

Thailand Artixio – Regulatory affairs consulting expert

Thailand

Indonesia Artixio – Regulatory affairs consulting expert

Indonesia

Philippines Artixio – Regulatory affairs consulting expert

Philippines

USA Artixio – Regulatory affairs consulting expert

USA

Japan Artixio – Regulatory affairs consulting expert

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Mexico COFEPRIS Updates on Medical Devices, Tariffs & Fees(December 2025)

Mexico COFEPRIS Updates on

Overview of December 2025 Regulatory Changes in Mexico Low risk Medical Device listing, application...

January 19, 2026
COFEPRIS Simplifies Medical Device Registration in Mexico (2025)

COFEPRIS Simplifies Medical Device

New Regulatory Agreement by COFEPRIS for Simplification of Medical Device Registration Procedures and Shorter...

February 16, 2026
COFEPRIS Reliance Pathway: Mexico Regulatory Update 2025

COFEPRIS Reliance Pathway: Mexico

Modernization of the COFEPRIS Regulatory Framework: Introduction of a Reliance Pathway Diario Oficial de...

January 3, 2026

Get in touch

×